Avapritinib
blueprint medicines
['erda', 'pathfinder', 'transform,(-transformi),(-transforme),(-transforma),(-transforms),(-transform1),(-transform 1),(-transform-1),(-transform2),(-transform 2),(-transform-2)', 'grail']
in the opening plenary session at #aacr23 yesterday, deborah schrag, md, mph, discussed the pathfinder trial and how #mced could transform cancer screening. 
GRAIL's mission is to detect cancer early, when it can be cured. 
Community Guidelines: https://t.co/x8f9DBN6rT 
The Cancer SIGNAL Podcast: https://t.co/6M8RXSAz8X